Legal Notices & Important Disclosures

This website may contain forward-looking statements within the meaning of applicable securities laws. To the extent that information on this website discusses financial projections, business plans, results of operations, product development, physician adoption, market expansion, revenue potential, or otherwise makes statements about future events, such statements are forward-looking in nature.

Forward-looking statements can be identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "projects," "forecasts," "may," "will," "should," and similar expressions.

Although Medfiniti, Inc. believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, a number of risks and uncertainties could cause actual results to differ materially. These risks include, but are not limited to: the pace of physician adoption and network expansion; reimbursement and coding changes by government and commercial payors; FDA regulatory developments affecting device clearance or labeling; competitive products and treatment alternatives; the availability of capital to fund operations and growth; clinical study results that may not replicate prior findings; and international regulatory and commercial risks in planned expansion markets.

Investors are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements speak only as of the date on which they are made. Medfiniti, Inc. does not undertake any obligation to update or revise any forward-looking statement to reflect new information, future events, or changed circumstances, except as may be required by law.

This website does not constitute an offer or solicitation to purchase or sell securities. Any offering of securities by Medfiniti, Inc. will be made only by means of a formal offering document delivered to qualified investors. Prior operating results are not necessarily indicative of future performance.

Nothing on this website shall be construed as investment advice, financial advice, or a recommendation to invest in Medfiniti, Inc. Any offering of securities will be conducted exclusively through formal offering documents delivered to qualified investors in jurisdictions where such offers are lawfully permitted. Access to this website does not establish any investor relationship, contractual commitment, or obligation on the part of Medfiniti, Inc.

Medfiniti, Inc. is a Florida corporation headquartered in Tampa, Florida. Any offering of securities by the Company is or will be conducted in compliance with the Florida Securities and Investor Protection Act, Chapter 517, Florida Statutes, and applicable exemptions thereunder, including applicable notice filing requirements with the Florida Office of Financial Regulation. This website does not constitute a general solicitation in any jurisdiction where such solicitation is prohibited.

Access to certain materials available through this website, including materials accessible through the investor data room, may be limited to accredited investors as defined under Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended. By requesting access to such materials, you represent that you qualify as an accredited investor and that you are accessing such materials for informational purposes in connection with a potential private investment.

Certain content on this website describes clinical procedures, device performance, and physician outcomes associated with the HemWell MD platform. This content is provided for informational purposes only and is directed to licensed medical professionals and investors conducting due diligence. Efficacy data cited on this website is based on pooled pilot studies and case series. Randomized controlled trial data is pending. Individual results may vary. Nothing on this website constitutes medical advice or a clinical recommendation.

All content on this website, including text, graphics, logos, images, and data, is the property of Medfiniti, Inc. or its licensors and is protected under applicable United States copyright, trademark, and intellectual property laws. Unauthorized reproduction or use of any content is strictly prohibited.